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It was previously shown that a high plasma concentration of non-esterified fatty acids (NEFA)
persisted after a fatty breakfast, but not after an isoenergetic carbohydrate breakfast, adversely
affecting glucose tolerance. The higher concentration after the fatty breakfast may in part have
been a result of different mobilization rates of fatty acids. This factor can be investigated as
NEFA mobilized from tissues are monounsaturated to a greater extent than those deposited from
a typical meal. Twenty-four middle-aged healthy Caucasian men were given oral glucose
tolerance tests (OGTT), and for 28 d isoenergetic breakfasts of similar fat composition but of
low (L) or moderate (M) fat content. The composition of NEFA in fasting and postprandial
plasma was determined on days 1 and 29. No significant treatment differences in fasting NEFA
composition occurred on day 29. During the OGTT and 0±1 h following breakfast there was an
increase in plasma long-chain saturated NEFA but a decrease in monounsaturated NEFA (mg/
100 mg total NEFA; P , 0´001). Between 1 and 3 h following breakfast treatment differences
occurred for total saturated and total monounsaturated fatty acids (mg/100 mg total NEFA;
P , 0´05), expressed as an increase in 18:1 and decreases in 16:0 and 17:0 in treatment M
relative to treatment L P , 0´05: Serum insulin attained 35 and 65 mU/l in treatments M and
L respectively during this period. Negative correlations were found between 16:0 in fasting
plasma and both waist:hip circumference P  0´0009 and insulin response curve area during
OGTT (within treatment M, P  0´0001). It is concluded that a normal postprandial insulin
response is associated with a rapid change in plasma saturated:monounsaturated NEFA. It is
proposed that this change is the result of a variable suppression of fat mobilization, which may
partly account for a large difference in postprandial total plasma NEFA between fatty and
carbohydrate meals.
Non-esterified fatty acids: Insulin: Dietary fat: Dietary carbohydrate
High circulating concentrations of non-esterified fatty acids
(NEFA) have emerged as important risk factors for a
variety of complex metabolic disorders. These disorders
include non-insulin-dependent diabetes mellitus, dyslipi-
daemia, insulin resistance, hyperinsulinaemia and athero-
sclerotic cardiovascular disease (Frayn et al. 1997; Byrne et
al. 1998). In a concentration-dependent manner NEFA
decrease insulin binding and receptor-mediated insulin
degradation in liver cells (Svedberg et al. 1990). The
importance of elevated portal NEFA is supported by the
observation that obese subjects, with high circulating
NEFA concentrations, have fewer binding sites for insulin
in the hepatocytes (Arner et al. 1986).
Chylomicrons are hydrolysed at the capillary endothe-
lium by the action of lipoprotein lipase. This process causes
a continuous influx of fatty acids into adipocytes. However,
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venous plasma as a result of the activity of intracellular
hormone-sensitive lipase HSL. Thus, adipose tissue
triacylglycerols (TAG) exist in a continuous dynamic
state (Frayn, 1993). Following a fatty meal the influx
greatly exceeds the efflux, as the efflux is suppressed by the
action of insulin on HSL. Circulating NEFA are rapidly
metabolized by other tissues, as they have a turnover of
only a few minutes (Friderickson & Gordon, 1958a,b).
Consequently, they influence the availability of glucose by
a fatty acid-mediated inhibition of plasma glucose
clearance and cellular uptake in the insulin-stimulated
state (Wolfe, 1998). We previously found that a relatively
small increase in fat consumption from isoenergetic
breakfasts was associated with a relatively large increase
in plasma NEFA concentration that persisted for at least
5 h. The NEFA were then associated with reduced glucose
tolerance that was caused either by the breakfast on day 29
or by the effect of all breakfasts for days 1±29 (Frape et al.
1998).
Following consumption of a fatty meal containing 80 g
fat and at least 80 g carbohydrate (v. 5´5 and 25´7 g fat and
113 and 56 g carbohydrate in the two meals in the present
study) by healthy subjects, Griffiths et al. (1994) and Frayn
et al. (1997) concluded that more than 80 % of the venous
NEFA draining adipose tissue were meal-derived through
the activity of lipoprotein lipase. We questioned whether
there may be an endogenous origin for a significant
proportion of the raised postprandial NEFA following a
moderately fatty breakfast. The origin of this NEFA may be
elucidated by determining its fatty acid composition, and
specifically the relative proportions of long-chain saturated
and monounsaturated fatty acids. This procedure was
previously adopted by Connor et al. (1996).
It was surmised that the difference between treatments in
the carbohydrate content of the isoenergetic breakfasts, and
the resulting insulin responses, would have been closely
associated with a difference in the composition of
postprandial NEFA in middle-aged men. This composition
was now determined in an endeavour to understand the
large treatment difference in plasma total NEFA concen-
tration. Evidence from experiments on rabbits indicates that
mobilized endogenous fatty acids are considerably less
saturated than the fatty acids of adipose tissue sources from
which they originate (Connor et al. 1996). Insulin response
associated with insulin resistance, or the consumption of a
low-carbohydrate meal, may fail to adequately suppress
postprandial intracellular fat mobilization. Consequently,
monounsaturated fatty acids, as a proportion of total plasma
NEFA, should not decrease to the extent that they may do
following a carbohydrate meal.
Experimental methods
Subjects and diets
Full details of design, procedures, statistical methods and
composition of the test meals have been reported
previously (Frape et al. 1998). Twenty-four middle-aged
non-smoking healthy Caucasian men aged 35±65 years
(Table 1) were given low-fat (L; composed of 86 g corn
flakes1300 ml semi-skimmed milk1250 ml orange juice,
providing 5´5 g fat and 113 g carbohydrate), or moderately
fatty (M; a pastie weighing 86 g, composed of a lean meat±
vegetable mixture in a pastry covering, in which the fat was
predominately butter, individually prepared by Country &
Colonial, 18300 Me Âne Âtre Âol-sous-Sancerre, France and
providing 26 g fat and 56 g carbohydrate) isoenergetic
breakfasts for 28 d with control over the other two daily
meals (Frape et al. 1998). The fatty acid composition of the
two breakfast menus (Table 2) was determined by a GC
method of Medina et al. (1992).
There were twelve pairs of men matched according to
the characteristic: waist:hip circumference  fasting LDL-
cholesterol. The two dietary treatments were allocated at
random within pairs. The treatment breakfasts were each
taken with a cup of tea or coffee on days 2±28 at home
before 09.00 hours. Tea and coffee were not given on day
29. All subjects were provided with a low-fat cereal
evening meal that was eaten exclusively at 19.00 hours on
days 0 and 28. Subjects were then fasted until 09.00 hours
on days 1 and 29. On days 2±28, some freedom was given
in the composition of the two other daily meals taken at
midday and in the evening. The content of these meals was
recorded daily by each subject in a diary. High-fat foods
were avoided, fish was excluded and all meals were taken
at home. No subject received prescription drug treatment or
took any drug containing salicylic acid or sodium salicylate
during the course of the study.
On day 1 fasting blood characteristics were measured
and all subjects were given an oral glucose tolerance test
(OGTT) at 09.00 hours. The glucose load was 66 g glucose
monohydrate (60 g glucose) in approximately 400 ml
water. On day 29 each subject received their previously
allocated L or M breakfast at 09.00 hours, followed at
13.30 hours by an OGTT. Water was available for drinking
on both days 1 and 29. All test meals and metabolic
measurements were carried out in Papworth Hospital and
were synchronized within pairs on days 1 and 29.
Body weight, height and waist and hip circumferences
Table 1. Characteristics of the twenty-four male subjects on day 1
(Values are means and their standard deviations for twelve subjects)
Treatment group¼ L M
Mean SD Mean SD
Age (years) 48´1 8´2 50´6 8´0
Weight (kg) 79´7 6´5 80´3 7´9
BMI (kg/m2) 26´8 2´7 25´2 2´5
Waist:hip circumference 0´900 0´038 0´901 0´053
Fasting blood values
Insulin (mU/l) 6´55 6´43* 8´65 3´78*
Glucose (mmol/l) 5´10 0´58 4´98 0´42
TAG (mmol/l) 1´30 1´17 1´32 0´73
NEFA (mmol/l) 0´47 0´31 0´41 0´11
Total cholesterol (mmol/l) 5´69 1´41 5´85 1´08
LDL-cholesterol (mmol/l) 3´83 1´17 3´97 0´80
Areas under the curve during OGTT
Glucose (mmol/l.min) 824´8 195 739´3 99
TAG (mmol/l.min) 158´2 132 160´1 87
NEFA (mmol/l.min) 24´6 17 23´0 13
L, low-fat breakfast; M, moderate-fat breakfast; TAG, triacylglycerols; NEFA,
non-esterified fatty acids; OGTT, oral glucose tolerance test.
* Median and interquartile range.
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trochanter of the femur respectively) were recorded in
fasting subjects by the same nurse at the same time of day
during the medical examination on days 1 and 29.
Waist:hip circumference varied from 0´80 to 1´05.
Comparisons between treatments were made over the
entire response period, but particularly 12.00 hours on
day 29, at which time it was previously found (Frape et al.
1998) that total plasma NEFA values differed between
treatments to the greatest extent. The null hypothesis was
that the fatty acid profile of the NEFA would be the same
for the two treatments, as the dietary fats had a similar fatty
acid composition (Table 2). Blood was sampled repeatedly
following both the OGTT and meals. The procedures for
the withdrawal and preparation of blood samples, and the
measurement of total NEFA content of the samples have
been described previously by Frape et al. (1997).
Analytical procedure
The plasma samples for the fatty acid analyses were held at
2708C before analysis. The fatty acid composition (mg/
100 mg) of the NEFA and fasting TAG samples was
determined by GC after preparative TLC (one subject per
plate) of the plasma lipids extracted by a modification of
the procedure of Bligh & Dyer (1959). All reagents were
analytical grade; in addition, chloroform and diethyl ether
were further purified by redistillation. Water was glass
distilled. Analytical processing was carried out in Decon 90
(BDH, Poole, Dorset, UK)-cleaned chloroform-rinsed glass
tubes. TLC plates were cleaned by pre-elution with solvent
mixture of the composition to be used for chromatography,
then air-dried at room temperature before application of
samples. Plasma (200 ml) was added to 4 ml saline (0´9 %
NaCl, w/v), which was then acidified (using a few drops of
1 M-HCl) to pH 4´0±4´5. Methanol (10 ml) and chloroform
(5 ml) were added, and the mixture was mixed thoroughly.
A further 5 ml saline and 5 ml chloroform were then
added, vortexed and centrifuged (1500 rpm, 48C, 10 min).
The upper aqueous layer was removed by aspiration and the
lower chloroform layer containing the lipids was collected
and evaporated to dryness under a gentle stream of O2-free
N2. The dry sample was redissolved in a small volume of
chloroform (approximately 100 ml) for TLC using What-
man TLC plates (20cm  20cm  1000mm; Type code
PK6F silica gel 60A8; Whatman International Ltd.,
Maidstone, Kent, UK). The plates were developed in
hexane±chloroform±diethyl ether±glacial acetic acid
(120:15:15:1´5, by vol.) The NEFA and TAG bands (Rf
values of 0´28 and 0´45 respectively) were identified in u.v.
light and scraped into glass tubes. The samples were
extracted with chloroform, evaporated under Ar and stored
at 2708C in screw-capped vials. The TAG were hydrolysed
overnight under N2 in the dark at room temperature, using
3 ml of a solution containing 1 g KOH, 10 ml diethyl ether,
10 ml methanol, 2 ml water. Water (1 ml) was added and
the samples were acidified with 3 M-HCl and extracted
twice with 3 ml diethyl ether. The diethyl ether extracts
were washed with water, and evaporated under a stream of
N2. The samples were redissolved in 2 ml dichloromethane
and transferred to screw-capped vials, in which they were
stored under Ar at 2708C. Before derivatization the
samples were evaporated to dryness under a gentle stream
of N2. A few drops of methanol were then added to both the
NEFA and the TAG hydrolysate samples, followed by 1 ml
freshly prepared diazomethane (solution in diethyl ether) to
convert the fatty acids to their methyl esters. After 10 min
the excess diazomethane was evaporated under a gentle
stream of N2 and the fatty acid methyl esters redissolved in
hexane and stored at 2208C under Ar before GC analysis.
GC was carried using a Vega 6130 gas chromatograph
(Carlo Erba Instruments, Milan, Italy), with a 30 m DB-1
fused silica capillary column (i.d. 0´32 mm and film
thickness 0´1 mm; J&W Scientific, Folsom, CA, USA).
The temperature was programmed to increase from 50 to
1208Ca t1 0 8C/min, from 120 to 2008Ca t4 8C/min, from
200 to 2808Ca t3 8C/min, and then at 2808C for 10 min. H2
carrier gas was used at an inlet pressure of 80 kPa. A 2 ml
portion of each sample was injected using an AS800
autosampler (Carlo Erba Instruments) via a split±splitless
injector operated in the splitless mode. Detection was by a
flame-ionization detector, and the output recorded using a
DP800 integrator (Carlo Erba Instruments). The injector
and detector temperatures were 270 and 2808C respec-
tively.
Identification of peaks was achieved by GC retention
times with reference to authentic standards, and by GC±
MS. The retention times, areas and peak heights of the
predominant fatty acid peaks were recorded. Each peak was
expressed both as a percentage (mg/100 mg) of the total
area and height of all the predominant and identified peaks,
and in mg/l plasma, for two blood sampling times on day 1
and five sampling times on day 29.
Statistical analysis
Responses for all repeated measurement variables were
summarized at individual subject level. Variables not
normally distributed were loge-transformed towards nor-
mality. The responses from fasting of total saturated and
Table 2. Fatty acid compositions (mg/100 mg total fatty acids) of the
breakfast meals and the fasting plasma triacylglycerols (TAG) and
non-esterified fatty acids (NEFA) for healthy middle-aged men on
day 29 of the study*²
(Plasma values are means with their standard errors for twelve
subjects)
TAG NEFA
Meal L M L M
L M Mean SEM Mean SEM Mean SEM Mean SEM
14:0 8´7 9´1 2´0 0´23 2´3 0´21 3´0 0´29 2´7 0´24
16:0 24´4 25´1 30´6 0´82 28´6 1´01 32´7 1´09 30´9 0´88
16:1 2´3 3´1 3´2 0´27 3´8 0´38 2´4 0´20 3´4 0´48
17:0 0 1´3 0´4 0´10 0´4 0´08 0´8 0´09 0´8 0´06
18:0 9´6 12´2 5´1 0´58 6´1 1´12 16´5 1´09 16´0 1´01
18:1 29´6 29´3 42´8 1´56 42´2 1´93 31´9 1´50 33´4 1´52
18:2 12´2 5´3 14´7 1´26 15´2 1´39 12´1 1´12 12´2 1´05
20:4 0 0´3 0´7 0´11 0´9 0´18 0´5 0´16 0´4 0´09
22:6 0 0´1 0´4 0´09 0´4 0´04 0´1 0´04 0´1 0´05
L, low-fat breakfast; M, moderate-fat breakfast.
* For details of subjects and procedures, see Table 1 and p. 738.
² There were no significant differences between treatments for any fatty acid:
P . 0´05:
739 Fat and CHO meals and plasma insulin and NEFAmonounsaturated acids, and 16:0/18:1, were analysed
separately by ANOVA. Time means for individual fatty
acids were compared by t test, where ANOVA indicated a
significant treatment effect. Areas under the curve (AUC)
and incremental areas from the baseline were calculated by
applying the trapezium rule to time points (Altman, 1991).
Statistical significance was accepted at P , 0´05: Standard
errors of the mean indicate the variation within treatment.
The Pearson correlation coefficient was employed to assess
associations. All comparisons were carried out with SPSS
for Windows version 9.0 (SPSS Inc., Chicago, IL, USA)
and, where appropriate, by Microsoft Excel 97 for
Windows software (Microsoft Corporation, Seattle, WA,
USA).
Ethical considerations
The protocol for the experiment was approved by the
Huntingdon Area Medical Ethics Committee, and all
subjects gave informed written consent to participate. The
investigations were carried out in accordance with the
principles of the Declaration of Helsinki.
Results
Fatty acid comparisons
We compared long-chain saturated (C14,C 16,C 17 and C18)
and monounsaturated (C16 and C18) fatty acids, constituting
89´9 % of the total measured fatty acids of plasma NEFA
during the OGTT and during the postprandial period
following breakfast. All plasma values given in tables and
figures represent the means of twelve subjects. The fatty
acid compositions of the two breakfast meals given at 09.00
hours on days 1±29 were very similar, and are shown in
Table 2. Neither the fatty acid composition of the fasting
plasma NEFA nor that of the fasting plasma TAG measured
either as mg/100 mg total fatty acids or as mg/l plasma,
differed significantly between treatments on day 29 (Table
2; mg/l plasma values are not shown).
We have demonstrated previously (Frape et al. 1998)
that the difference between treatments L and M on day 29
with regard to total NEFA content of plasma reached a
maximum at 12.00 hours, 3 h following the meal.
Furthermore, over the period 09.00±13.20 hours, the
NEFA AUC with treatment L was only 59 % of that with
treatment M. In the present study, long-chain saturated fatty
acids were examined separately from monounsaturated
fatty acids. ANOVA indicated significant treatment
differences over the postprandial period following break-
fast on day 29 for total saturated P  0´027 and total
monounsaturated P  0´0026 fatty acids expressed as mg/
100 mg NEFA. The responses at 10.00 hours did not differ
significantly from those at 12.00 hours. The values for
individual fatty acids at 12.00 hours are given in Fig. 1.
The insulin responses during the OGTT on days 1 and 29
were considerable with both treatments (see p. 741) and so
differences were not expected in the associated responses of
any fatty acid to the OGTT over 120 min. This was the case
andsothevaluesforthetwotreatmentsandfordays1and29
were combined (Table 3). The proportion of the saturated
fatty acids increased and that of monounsaturated fatty acids
decreased following the oral glucose dose P , 0´002: This
response was in accordance with that observed 1 h after
consumption of the breakfast meal for both treatments
(Table 4; Fig. 2 for monounsaturated fatty acids). Saturated
fatty acids gave a fractional response which was approxi-
mately 12x (data not shown) of the monounsaturated fatty
acid response (x). At 1 h after the meal the fatty acid
composition of the NEFA for the two treatments, L and M,
diverged. At 12.00 hours, 3 h after the treatment L meal, the
proportions of 16:0 and 17:0 were greater P  0´026 and
0´0055 respectively) and that of 18:1 was lower P 
0´0027 than those for treatment M (Fig. 1).
Fig. 1. Non-esterified fatty acid (NEFA) composition of plasma (mg/
100 mg total NEFA) in healthy middle-aged men at 12.00 hours, 3 h after
consumption of either a low-fat (L; A) or moderate-fat (M; B) breakfast
meal on day 29. For details of the breakfast meals and procedures, see
Table 2 and p. 738. Values are means with their standard errors
represented by vertical bars for twelve subjects. Mean values were
significantly different between treatments: *P , 0´05; **P , 0´01:
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Before treatment allocation there was no significant
difference in the plasma insulin response to an oral glucose
dose on day 1. However, there were significant differences
between treatments in the plasma insulin response to the
breakfast (incremental loge AUC, P  0´051) and to the
oral glucose dose (loge AUC, P  0´038) on day 29. On
day 29, comparisons between treatments at 10.00
P  0´014, 14.30 P  0´062 and 15.00 P  0´024
hours indicated differences in insulin response (loge mU/l)
(Fig. 3).
16:0/18:1 response
From fasting to 13.30 hours on day 29, the 16:0/18:1
plasma values indicated a difference in response between
treatments P , 0´01: From fasting to 3 h after the
breakfast, this ratio increased from 1´06 (SE 0´084) to
1´78 (SE 0´214) for treatment L (a 67 % increase), but it
increased by only 23 % from 0´95 (SE 0´064) to 1´17 (SE
0´068) for treatment M (Fig. 4). Adipose tissue fat has been
reported to have a mean 16:0/18:1 of 0´49 (range 0´46±
0´56; Heffernan, 1963; Brook, 1971; Kokatnur et al. 1979;
Pittet et al. 1979; Malcom et al. 1989), compared with the
corresponding values for the fat in meals of 0´83 for L and
0´86 for M. The plasma ratio for treatment M was closer to
that for adipose tissue fat and less than that for treatment L
at 12.00 hours P  0´012: At 13.30 hours serum insulin
had returned to fasting concentrations, at which time the
saturated and monounsaturated fatty acid profiles were very
similar between treatments. The subsequent increases in
16:0/18:0 during the OGTT were from 1´00 (SE 0´037) to
1´62 (SE 0´175) for treatment L and from 1´03 (SE 0´046) to
1´66 (SE 0´151) for treatment M. These increases were
similar to those for treatment L after the breakfast (Fig. 4).
Associations between 16:0 and insulin and between 16:0
and waist:hip circumference
16:0 represented a major fraction of the NEFA, especially
during the insulin response to digestible carbohydrate. It
was expected that its concentration (mg/100 mg total
NEFA) would be negatively correlated, especially within
treatment M, to insulin AUC response after the breakfast
meal. 16:0 was correlated with the contemporary plasma
loge insulin AUC (r 20´47, P  0´02 at 11.00 hours on
day 1, before treatment allocation, during the OGTT. At
12.00 hours on day 29, following the meal, the correlation
of plasma 16:0 with the contemporary loge insulin AUC
was stronger within treatment M (r 20´91, P  0´0001)
than within treatment L (r 20´52, P  0´08). For times
10.00 and 12.00 hours combined, the corresponding values
Table 3. Plasma non-esterified fatty acids (mg/100 mg total non-esterified fatty acids) in healthy middle-
aged men before and 120 min after a 60 g oral glucose dose*
(Values are means with their standard errors for twenty-four subjects)
Pre-dose² Post-dose² Statistical significance of
difference between means: P
Fatty acid Mean SEM Mean SEM
14:0 3´27 0´17 4´46 0´34 ,0´0001
16:0 32´16 0´53 35´40 0´85 ,0´0001
16:1 2´63 0´23 2´16 0´16 0´002
17:0 0´76 0´07 1´20 0´13 0´0002
18:0 14´82 0´79 20´03 0´90 ,0´0001
18:1 33´49 1´03 25´04 1´04 ,0´0001
18:2 12´27 0´83 10´82 0´98 0´054
20:4 0´35 0´05 0´67 0´18 0´04
* For details of procedures, see p. 738.
² Values are pooled from both treatment groups and from days 1 and 29 as individual values did not differ
significantly.
Table 4. Plasma non-esterified fatty acids (mg/100 mg total non-esterified fatty acids) in healthy middle-aged men immediately before (09.00
hours) and 1 h after (10.00 hours) consumption of a low-fat (L) or moderate-fat (M) breakfast meal on day 29*
(Values are means with their standard errors for twelve subjects)
Treatment group¼ L Statistical significance
of difference between
means: P
M Statistical significance
of difference between
means: P 09.00 hours 10.00 hours 09.00 hours 10.00 hours
Mean SEM Mean SEM Mean SEM Mean SEM
14:0 2´97 0´29 4´14 0´34 0´008 2´69 0´24 3´60 0´27 0´003
16:0 32´69 1´09 36´23 1´61 0´013 30´93 0´88 33´59 0´94 0´018
16:1 2´43 0´20 1´94 0´18 0´040 3´40 0´48 2´37 0´24 0´007
17:0 0´84 0´09 1´11 0´20 0´130 0´81 0´06 1´05 0´09 0´010
18:0 16´52 1´09 21´21 1´36 0´0003 16´01 1´01 19´28 1´31 0´058
18:1 31´89 1´50 24´76 1´82 0´0003 33´4 1´52 29´17 1´50 0´022
18:2 12´10 1´12 9´84 1´47 0´027 12´21 1´05 10´02 0´80 0´017
20:4 0´48 0´16 0´61 0´14 0´320 0´43 0´09 0´66 0´13 0´120
* For details of breakfast meals and procedures, see Table 2 and p. 738.
741 Fat and CHO meals and plasma insulin and NEFAwere r 20´79, P  0´002 and r 20´57, P  0´051 for
treatments M and L respectively.
Intra-abdominal fat is subject to a high flux (Arner,
1995). A high waist:hip circumference should therefore be
associated with a relatively higher proportion of 18:1 and a
lower proportion of 16:0 (mg/100 mg plasma total NEFA),
especially when plasma insulin is at post-absorptive
concentrations (Arner, 1995). Indeed, we found that fasting
16:0 on day 1 was correlated with waist:hip circumference
on day 1, r 20´63, P  0´0009 (principally an effect of
differences in waist measurement; r 20´57, P  0´003),
whereas the corresponding values for 18:1 were r 0´43,
P  0´04:
Discussion
The saturated and monounsaturated fatty acid composition
of NEFA is the result of: (1) different individual
mobilization rates of fatty acids by HSL (Connor et al.
1996); (2) the composition and extent of leak-back of fatty
acids from lipoprotein lipase activity (Fielding & Frayn,
1998); (3) differential clearance rates, (not differentiated in
our data). Nevertheless, our two diets had very similar fatty
acid compositions, and plasma TAG concentrations, of low
chylomicron content, did not differ significantly between
treatments throughout day 29 (Frape et al.1998). Leak-back
composition should not have been very different between
treatments, and the composition of fasting plasma TAG and
NEFA, and the fasting insulin were all very similar
between treatments (Table 2 and Fig. 3). Turn-over rates
of isotopically-labelled 16:0 and 18:1 were found to be
similar (Friderickson & Gordon 1958a,b), as were the rates
of
13CO2 recovery in breath of absorbed labelled 16:0 and
18:1 (Jones et al. 1999). Thus, disposal rates of these two
predominant circulating fatty acids are similar. Although an
influence in our data from leak-back and clearance cannot
be excluded, a large difference in the tendency of
individual fatty acids to be mobilized has been reported
(see p. 742).
Mobilization of tissue fatty acids
HSL activity is inhibited in healthy young subjects when
plasma insulin concentration exceeds 13±16 mU/l (Frayn
et al. 1997). Nevertheless, there is a dose±response
relationship between serum insulin concentration and the
postprandial appearance of plasma fatty acids, a relation-
ship that is more pronounced in middle-aged and obese
subjects. A small increment in plasma insulin concentration
caused a marked suppression of palmitate (16:0) flux in
lean women, but the flux remained substantial in obese
women despite greater plasma insulin concentrations
(Jensen et al. 1989). Moreover, the rate of lipolysis of
stored fat and the rate of appearance of plasma fatty acids
depend on the plasma glucose and insulin concentrations,
but the relationship between insulin sensitivity and plasma
Fig. 2. Monounsaturated 16 : 1  18 : 1 non-esterified fatty acid (NEFA)
composition of plasma (mg/100 mg total NEFA) in healthy middle-aged men
before (day 1; a) and after (day 29; b) consuming a low-fat (L; W) or moderate-fat
(M; X) breakfast meal for 28 d. Fasting fatty acid compositions are shown at 09.00
hours on both days. An oral glucose dose was given at 09´00 hours on day 1 and at
13.30 hours on day 29. The breakfast meal was consumed at 09.00 hours on day
29. For details of the breakfast meals and procedures, see Table 2 and p. 738.
Values are means with their standard errors represented by vertical bars for twelve
subjects. The change in plasma monounsaturated fatty acid compositions from
fasting to 13.30 hours on day 29 was significantly different between treatments
P  0´0026: Mean values were significantly different between treatments within
times: *P , 0´05: Saturated fatty acids C14  C16  C17  C18 gave a fractional
response which was approximately 12x (data not shown) of the monounsaturated
fatty acids response (x). OGTT, oral glucose tolerance test.
742 D. L. Frape et al.Fig.4.Plasmanon-esterifiedfattyacidratios,16:0/18:0(mg/mg),inhealthy
middle-aged men before (day 1; a) and after (day 29; b) consuming a low-fat
(L; W) or moderate-fat (M; X) breakfast meal for 28 d. Fasting ratios are
shownat09.00 hoursonbothdays.Anoral glucosedosewas givenat09.00
hours on day 1 and at 13.30 hours on day 29. The breakfast meal was
consumed at 09.00 hours on day 29. For details of the breakfast meals and
procedures, see Table 2 and p. 738. Values are means with their standard
errors represented by vertical bars for twelve subjects. ANOVA showed
significant differences between treatments on day 29 from 09.00 to 13.30
hours P , 0´01: Mean values were significantly different between treat-
ments within times: *P , 0´05: OGTT, oral glucose tolerance test.
Fig. 3. Plasma insulin concentration (mU/l) in healthy middle-aged men
before (day 1; a) and after (day 29; b) consuming a low-fat (L; W)o r
moderate-fat (M; X) breakfast meal for 28 d. Fasting insulin levels are
shown at 09.00 hours on both days. An oral glucose dose was given at
09.00 hours on day 1 and at 13.30 hours on day 29. The breakfast meal
was consumed at 09.00 hours on day 29. For details of the breakfast meals
and procedures, see Table 2 and p. 738. Values are means with their
standard errors represented by vertical bars for twelve subjects. ANOVA of
loge transformed values showed significant differences between treatments
on day 29 from 09.00 to 13.30 hours and from 13.30 to 15.30 hours P 
0´05: Mean values were significantly different between treatments within
times: *P , 0´05: OGTT, oral glucose tolerance test.
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postprandial period than during fasting (Ferrannini et al.
1997). At plasma glucose and insulin concentrations of
7´2 mmol/l and 20±25 mU/l respectively, both lipolysis
and the rate of appearance of plasma fatty acids were
suppressed. However, when plasma glucose and insulin
were held at 10´5 mmol/l and 40 mU/l respectively, the rate
of appearance of plasma fatty acids was further suppressed
(Wolfe & Peters, 1987). Thus, postprandial intracellular fat
mobilization rate depends on plasma insulin concentration
and is suppressed to a lesser extent in obese and older
subjects than in lean and younger subjects.
During the first 90 min of the OGTT the serum insulin
exceeded 35 mU/l with both treatment groups on days 1
and 29. This response was associated, proportionately
and between treatments, with similar increases in
saturated fatty acids and decreases in monounsaturated
fatty acids in the NEFA P , 0´002: However, follow-
ing consumption of the breakfast meals, the insulin
response was elevated in both treatment groups, but was
significantly higher for treatment L P  0´05: Over this
meal period the fatty acids 16:0 and 18:1 contributed
over 60 mg/100 mg total measured plasma NEFA. 18:1
was significantly higher P , 0´01; whereas 16:0 was
significantly lower P , 0´05 for treatment M than
treatment L (Fig. 1).
The mobilization of fatty acids by HSL in adipose
tissue of laboratory animals is positively correlated with
unsaturation (Raclot & Groscolas, 1993; Connor et al.
1996). This observation is consistent with our evidence that
a meal of carbohydrate should be closely associated with a
decrease in the relative proportions of monounsaturated
fatty acids and an increase in the relative proportions of
saturated fatty acids in total NEFA.
As the proportions of saturated fatty acids relative to
monounsaturated fatty acids in the NEFA differed
between treatments following breakfast at 12.00 hours
but not in the fasting plasma, an explanation was sought.
Circulating 17:0 fatty acid was measured, as odd-
numbered -C fatty acids are not synthesized endogenously
and must be of dietary origin. Indeed, it has been
proposed that 17:0 in subcutaneous adipose tissue (Wolk
et al. 1998) and 15:0 in serum (Smedman et al. 1999)
might be valid biological markers of long-term milk-fat
intake. 17:0 was not detectable either in the evening meal
for both treatment groups on day 28 or in the breakfast for
treatment L on day 29. By contrast, the proportion of
17:0 in the NEFA was greater for treatment L than for
treatment M at 12.00 hours on day 29 P  0´0055: This
proportional response was consistent with that of other
saturates, indicating suppression of intracellular fat
mobilization. Consumption of 17:0 during days 2±28
was assessed blind from the individual food diaries.
Dietary 17:0 was found to be positively correlated, within
treatment, to plasma 17:0 (mg/100 mg NEFA) when
plasma insulin was at post-absorptive concentrations on
day 29 (r 0´46, P , 0´05), indicating tissue storage as its
source. These data support a conclusion that the raised
total NEFA content of treatment M plasma 3 h after the
meal was derived to a measurable extent from fatty acids
mobilized in storage tissues.
Associations amongst response characteristics
Arner (1995) observed that the rate of lipolysis by HSL is
low in the subcutaneous femoral and gluteal regions,
intermediate in the subcutaneous abdominal region and
high in the visceral (omental) region, and Coon et al.
(1992) found a correlation between waist:hip circumfer-
ence and the rate of decline of plasma NEFA concentration
during euglycaemic hyperinsulinaemic clamping. Byrne et
al. (1998) reported that fasting insulin levels and waist:hip
circumference predicted percentage NEFA suppression in
men. The negative correlations in the present study
between fasting 16:0 and waist:hip circumference
P 0´0009; and between 16:0 and contemporary loge
insulin AUC P 0´0001 are consistent with this evidence,
but not proof of cause and effect. A raised proportion of
NEFA as 16:0 may reflect a suppression of endogenous fat
mobilization. The mobilization of omental fat is resistant to
suppression by raised postprandial plasma insulin, espe-
cially in subjects with a high waist:hip circumference.
Conclusions
The net outward flux of NEFA was greater, and its profile
different, during the 1±3 h postprandial period for treat-
ment M than for treatment L. This difference occurred at a
time when plasma insulin concentration was lower for
treatment M, but which greatly exceeded 13±16 mU/l in
both groups. Thus, an adverse effect of a fatty meal on
glucose tolerance and insulin function may be expressed by
itsfailure toadequatelyinhibitintracellular fatmobilization.
It is concluded that a substantial rise in postprandial
plasma insulin concentration is associated with a rise in the
proportion of saturated fatty acids and a decrease in the
proportion of monounsaturated fatty acids in plasma
NEFA. This difference does not persist following a fatty
meal amongst middle-aged men. It is proposed that the
subjects who received a breakfast providing 26, rather than
5 g fat, especially those with an excessive waist:hip
circumference, may have been less able to suppress
postprandial intracellular fat mobilization. They appear to
have expressed insulin resistance, notably by a strong
negative correlation between the postprandial plasma
concentrations of the NEFA 16:0 and insulin. Insulin
resistance and an excessive waist:hip circumference appear
to be associated with elevated postprandial plasma NEFA
that is relatively rich in monounsaturated fatty acids. These
observations are in accordance with recent conclusions
from a cross-sectional survey by Han et al. (1999) that type
2 diabetes is strongly associated with a high waist:hip
circumference. Further investigation is required to clearly
differentiate between rates of mobilization and clearance of
postprandial NEFA in subjects receiving isoenergetic fatty
and carbohydrate meals.
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